Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
52.3M
-
Number of holders
-
70
-
Total 13F shares, excl. options
-
31.9M
-
Shares change
-
-431K
-
Total reported value, excl. options
-
$84M
-
Value change
-
-$1.54M
-
Number of buys
-
24
-
Number of sells
-
-34
-
Price
-
$2.63
Significant Holders of ENZO BIOCHEM INC - Common Stock, par value $0.01 per share (ENZB) as of Q4 2019
82 filings reported holding ENZB - ENZO BIOCHEM INC - Common Stock, par value $0.01 per share as of Q4 2019.
ENZO BIOCHEM INC - Common Stock, par value $0.01 per share (ENZB) has 70 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31.9M shares
of 52.3M outstanding shares and own 61.08% of the company stock.
Largest 10 shareholders include HARBERT FUND ADVISORS, INC. (5.62M shares), Evermore Global Advisors, LLC (4.01M shares), BlackRock Inc. (3.7M shares), WELLINGTON MANAGEMENT GROUP LLP (3.58M shares), RENAISSANCE TECHNOLOGIES LLC (3.35M shares), VANGUARD GROUP INC (2.16M shares), DIMENSIONAL FUND ADVISORS LP (2.13M shares), ARIEL INVESTMENTS, LLC (966K shares), STATE STREET CORP (796K shares), and Fondren Management LP (727K shares).
This table shows the top 70 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.